Literature DB >> 33197575

The roles of adenosine deaminase in autoimmune diseases.

Zhao-Wei Gao1, Xi Wang1, Hui-Zhong Zhang1, Fang Lin1, Chong Liu1, Ke Dong2.   

Abstract

Autoimmune diseases patients are characterized by the autoimmune disorders, whose immune system can't distinguish between auto- and foreign- antigens. Thus, Immune homeostasis disorder is the key factor for autoimmune diseases development. Adenosine deaminase (ADA) is the degrading enzyme for an immunosuppressive signal - adenosine, and play an important role in immune homeostasis regulation. Increasing evidences have shown that ADA is involved in various autoimmune diseases. ADA activity were changed in multiple autoimmune diseases patients and could be served as a biomarker for clinical diagnosis. In this study, we analyze the change of ADA activity in patients with autoimmune diseases, and we underline its potential diagnostic value for autoimmune diseases patients.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Adenosine deaminase; Autoimmune disease; Immune regulation

Year:  2020        PMID: 33197575     DOI: 10.1016/j.autrev.2020.102709

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  11 in total

Review 1.  Deciphering the tRNA-derived small RNAs: origin, development, and future.

Authors:  Bowen Liu; Jinling Cao; Xiangyun Wang; Chunlei Guo; Yunxia Liu; Tianjiao Wang
Journal:  Cell Death Dis       Date:  2021-12-21       Impact factor: 8.469

2.  Increased serum adenosine deaminase activity in patients with adult-onset Still's disease.

Authors:  Zhiye Xu; Linyu Geng; LiLi Guo; Hongyan Song; Jie Pan; Han Shen; Sen Wang
Journal:  BMC Immunol       Date:  2022-01-29       Impact factor: 3.615

3.  ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies.

Authors:  Der-Yuan Chen; Yen-Hsiang Huang; Yi-Ming Chen; Jeremy J W Chen; Tsung-Ying Yang; Gee-Chen Chang; Kuo-Tung Tang
Journal:  Lupus Sci Med       Date:  2021-11

4.  Quercetin mitigates rheumatoid arthritis by inhibiting adenosine deaminase in rats.

Authors:  Karim Samy El-Said; Amira Atta; Maysa A Mobasher; Mousa O Germoush; Tarek M Mohamed; Maha M Salem
Journal:  Mol Med       Date:  2022-02-22       Impact factor: 6.354

5.  Identification and Functional Characterization of Adenosine Deaminase in Mucor circinelloides: A Novel Potential Regulator of Nitrogen Utilization and Lipid Biosynthesis.

Authors:  Shaoqi Li; Junhuan Yang; Hassan Mohamed; Xiuwen Wang; Shuxian Pang; Chen Wu; Sergio López-García; Yuanda Song
Journal:  J Fungi (Basel)       Date:  2022-07-26

Review 6.  tiRNAs: Insights into Their Biogenesis, Functions, and Future Applications in Livestock Research.

Authors:  Fabio Sarais; Alvaro Perdomo-Sabogal; Klaus Wimmers; Siriluck Ponsuksili
Journal:  Noncoding RNA       Date:  2022-05-26

Review 7.  The regulatory mechanism and potential application of IL-23 in autoimmune diseases.

Authors:  De-Kai Xiong; Xiang Shi; Miao-Miao Han; Xing-Min Zhang; Na-Na Wu; Xiu-Yue Sheng; Ji-Nian Wang
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

8.  Diagnostic performance of adenosine deaminase for abdominal tuberculosis: A systematic review and meta-analysis.

Authors:  Ruixi Zhou; Xia Qiu; Junjie Ying; Yan Yue; Tiechao Ruan; Luting Yu; Qian Liu; Xuemei Sun; Shaopu Wang; Yi Qu; Xihong Li; Dezhi Mu
Journal:  Front Public Health       Date:  2022-09-21

Review 9.  Colorectal Cancer and Purinergic Signalling: An Overview.

Authors:  Gabriela Gonçalves Roliano; Juliana Hofstätter Azambuja; Veronica Toniazzo Brunetto; Hannah Elizabeth Butterfield; Antonio Nochi Kalil; Elizandra Braganhol
Journal:  Cancers (Basel)       Date:  2022-10-06       Impact factor: 6.575

10.  Increased levels of serum adenosine deaminase and increased risk of diabetic peripheral neuropathy in type 2 diabetes.

Authors:  Chao Yu; Lei Zhuang; Feng Xu; Li-Hua Zhao; Xiao-Hua Wang; Chun-Hua Wang; Li-Yan Ning; Xiu-Lin Zhang; Dong-Mei Zhang; Xue-Qin Wang; Jian-Bin Su
Journal:  Front Endocrinol (Lausanne)       Date:  2022-10-04       Impact factor: 6.055

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.